Author:
Aguilar-Olivos Nancy,Ornelas-Arroyo Sofía,Chavez-Tapia Norberto C.,Uribe Misael,Méndez-Sánchez Nahum
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Hsu YC, Ho HJ, Wu MS, et al. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology. 2013;58:150–7.
2. Méndez-Sánchez N, Uribe M. Chapter 17: Viral Hepatitis C-Associated hepatocellular Carcinoma. VIRAL HEPATITIS. Epidemiological, Clinical and Basic Concepts. Mexico: Masson Doyma, S.A; 2013. p. 156–65.
3. •• El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–73. e1261 This study summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on epidemiological studies, meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the US.
4. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–44.
5. Pichardo-Bahena R, Mendez-Sanchez N. Relation between hepatocarcinoma and hepatitis C virus infection. Rev Gastroenterol Mex. 2002;67 Suppl 2:S36–41.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献